                         SEQUENCE LISTING

<110>  Wang, Tian xin
 
<120>  Methods and agents to treat tumor cells and cancer

<130>  001

<150>  US 62649579
<151>  2018-03-29

<150>  US 62636838
<151>  2018-02-28

<150>  US 62631616
<151>  2018-02-16

<150>  US 62482982
<151>  2017-04-07

<150>  US 15/945,741
<151>  2018-04-05

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  affinity peptide

<400>  1

Gln Val Ser His Trp Val Ser Gly Leu Ala Glu Gly Ser Phe Gly 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic affinity peptide 2

<400>  2

Leu Ser His Thr Ser Gly Arg Val Glu Gly Ser Val Ser Leu Leu 
1               5                   10                  15  


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  affinity peptide

<400>  3

Cys Gln Met Trp Ala Pro Gln Trp Gly Pro Asp Cys 
1               5                   10          


<210>  4
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  affinity peptide

<400>  4

Cys Gly Ser Gly Ser Gln Leu Gly Pro Tyr Glu Leu Trp Glu Leu Ser 
1               5                   10                  15      


His 
    


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  affinity peptide

<400>  5

Leu Leu Gly Pro Tyr Glu Leu Trp Glu Leu Ser His 
1               5                   10          


<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  affinity peptide

<400>  6

Gln Leu Gly Pro Tyr Glu Leu Trp Glu Leu Ser His 
1               5                   10          


<210>  7
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  affinity peptide


<220>
<221>  DISULFID
<222>  (5)..(18)

<220>
<221>  DISULFID
<222>  (9)..(26)

<220>
<221>  DISULFID
<222>  (29)..(38)

<400>  7

Gly Pro Ser Leu Cys His Pro Glu Cys Gln Pro Gln Asn Gly Ser Val 
1               5                   10                  15      


Thr Cys Phe Gly Pro Glu Ala Asp Gln Cys Val Ala Cys Ala His Tyr 
            20                  25                  30          


Lys Asp Pro Pro Phe Cys Val Ala 
        35                  40  


<210>  8
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  affinity peptide


<220>
<221>  DISULFID
<222>  (4)..(27)

<400>  8

Val Ala Arg Cys Pro Ser Gly Val Lys Pro Asp Leu Ser Tyr Met Pro 
1               5                   10                  15      


Ile Trp Lys Phe Pro Asp Glu Glu Gly Ala Cys Gln Pro Leu 
            20                  25                  30  


<210>  9
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  affinity peptide

<400>  9

Val Leu Pro Lys Thr Leu Cys Gly Gly Gly Ser 
1               5                   10      


<210>  10
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  affinity peptide

<400>  10

Ala Cys Lys Tyr Pro Leu Gly His Gln Cys Gly Gly Gly Ser 
1               5                   10                  


<210>  11
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  affinity peptide


<220>
<221>  DISULFID
<222>  (1)..(12)

<400>  11

Cys Gln Tyr Asn Leu Ser Ser Arg Ala Leu Lys Cys Gly Pro Gly Pro 
1               5                   10                  15      


Gly 
    


